Outcome of Enterococcus faecalis infective endocardits according to the length of antibiotic therapy: Prelininary data from a cohort of 78 patients.

dc.contributor.authorPericàs, Juan M.
dc.contributor.authorCervera, Carlos
dc.contributor.authorMoreno Camacho, Ma. Asunción
dc.contributor.authorGarcía de la Mària, Cristina
dc.contributor.authorAlmela, M. (Manel)
dc.contributor.authorFalces Salvador, Carles
dc.contributor.authorQuintana, Eduard
dc.contributor.authorVidal, Bàrbara
dc.contributor.authorLlopis Pérez, Jaime
dc.contributor.authorFuster Pelfort, David
dc.contributor.authorMestres Lucio, Carlos-Alberto
dc.contributor.authorMarco Reverté, Francesc
dc.contributor.authorMiró Meda, José M. (José María), 1956-
dc.date.accessioned2018-03-06T12:40:06Z
dc.date.available2018-03-06T12:40:06Z
dc.date.issued2018-02-20
dc.date.updated2018-03-06T12:40:06Z
dc.description.abstractBackground International guidelines recommend 4 weeks of treatment with ampicillin plus gentamicin (A+G) for uncomplicated native valve Enterococcus faecalis infective endocarditis (EFIE) and 6 weeks in the remaining cases. Ampicillin plus ceftriaxone (A+C) is always recommended for at least 6w, with no available studies assessing its suitability for 4w. We aimed to investigate differences in the outcome of EFIE according to the duration (4 versus 6 weeks) of antibiotic treatment (A+G or A+C). Methods Retrospective analysis from a prospectively collected cohort of 78 EFIE patients treated with either A+G or A+C. Results 32 cases (41%) were treated with A+G (9 for 4w, 28%) and 46 (59%) with A+C (14 for 4w, 30%). No significant differences were found in 1-year mortality according to the type of treatment (31% and 24% in A+G and A+C, respectively; P = 0.646) or duration (26% and 27% at 4 and 6w, respectively; P = 0.863). Relapses were more frequent among survivors treated for 4w than in those treated for 6w (3/18 [17%] at 4w and 1/41 [2%] at 6w; P = 0.045). Three out of 4 (75%) relapses occurred in cirrhotic patients. Conclusions A 4-week course of antibiotic treatment might not be suitable neither for A+G nor A+C for treating uncomplicated native valve EFIE.
dc.format.extent12 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec677687
dc.identifier.idimarina3362489
dc.identifier.issn1932-6203
dc.identifier.pmid29462176
dc.identifier.urihttps://hdl.handle.net/2445/120473
dc.language.isoeng
dc.publisherPublic Library of Science (PLoS)
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1371/journal.pone.0192387
dc.relation.ispartofPLoS One, 2018, vol. 13, num. 2, p. e0192387
dc.relation.urihttps://doi.org/10.1371/journal.pone.0192387
dc.relation.urihttps://doi.org/10.1371/journal.pone.0196317
dc.rightscc-by (c) Pericàs, J.M. et al., 2018
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Genètica, Microbiologia i Estadística)
dc.subject.classificationMicrobiologia
dc.subject.classificationAntibiòtics
dc.subject.otherMicrobiology
dc.subject.otherAntibiotics
dc.titleOutcome of Enterococcus faecalis infective endocardits according to the length of antibiotic therapy: Prelininary data from a cohort of 78 patients.
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 2 de 2
Carregant...
Miniatura
Nom:
677687.pdf
Mida:
1.05 MB
Format:
Adobe Portable Document Format
Descripció:
Original article
Carregant...
Miniatura
Nom:
682289 .pdf
Mida:
446.9 KB
Format:
Adobe Portable Document Format
Descripció:
Correction